*Vaccines are essential for protecting people from infectious diseases, but the traditional process of making them can be time-consuming and expensive.

*Chemical engineers at the University of California, Berkeley, have developed a new way to make vaccines that is faster, cheaper, and more scalable*.

The new process, called "continuous manufacturing," involves using a continuous flow of materials

*rather than the traditional batch process, in which materials are added to a reactor and mixed together.

*This allows for more precise control over the manufacturing process and reduces the risk of contamination*.

The researchers say their new process could reduce the time it takes to make a vaccine from months to just a few days.

*This could make vaccines more affordable and accessible, especially for people in developing countries.

***

The researchers are currently working to scale up their process so that it can be used to produce vaccines on a commercial scale

- If successful, their work could revolutionize the way vaccines are made and help to protect more people from infectious diseases.

Here are some of the key benefits of the new continuous manufacturing process:

- Speed: The new process can reduce the time it takes to make a vaccine from months to just a few days.

- Cost-effectiveness: The new process is more cost-effective than the traditional batch process, making vaccines more affordable.

- Scalability: The new process can be scaled up to produce vaccines on a commercial scale.

- Precision: The new process allows for more precise control over the manufacturing process, reducing the risk of contamination.

- Accessibility: The new process could make vaccines more accessible to people in developing countries.